Close Menu

NEW YORK (360Dx) – Following Wednesday's release of Laboratory Corporation of America's third-quarter financial results, which missed the consensus Wall Street estimates on the top and bottom lines, Canaccord Genuity today downgraded the company's shares to a Hold rating from a previous Buy.

The investment bank also lowered its price target on LabCorp's shares to $162 from $195.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.